Mission Produce
AVO
12.51
-0.24
-1.88%
Mission Produce
US · AVO
#3185 by market cap
Listed 2020
12.51
-0.24
-1.88%
Live - 5344 symbols - heartbeat 273s ago
· 2026-10-08 08:35
Pre-market
12.41
-0.78%
After-hours
12.51
0.00%
- Market cap
- 1.10B
- P/E (TTM)i
- 312.75
- P/Bi
- 1.44
- EPSi
- 0.53
- Div yieldi
- 0.00%
- 52W posi
- 45%
Reader sentiment
Are you bullish or bearish on AVO?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 4.09, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +12.68% YoY
Margins
- Gross margin
- 11.55%
- Operating margin
- 4.69%
- Net margin
- 2.71%
Key ratios & quality
- Enterprise valuei
- 1.14B
- Altman Z-Scorei
- 4.09
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 859.90M | 883.30M | 862.30M | 891.70M | 1.05B | 953.90M | 1.23B | 1.39B |
| Gross profit | 54.00M | 154.70M | 124.60M | 124.50M | 89.80M | 83.30M | 152.50M | 160.70M |
| Selling & admin expenses | 35.30M | 48.20M | 56.20M | 63.60M | 77.50M | 76.40M | 86.80M | 95.50M |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 18.70M | 106.50M | 68.40M | 60.90M | 12.30M | 6.90M | 65.70M | 65.20M |
| Pretax profit | 88.60M | 96.00M | 43.80M | 66.00M | -31.20M | -900.00K | 60.40M | 61.90M |
| Tax | 16.20M | 24.30M | 15.00M | 21.10M | 3.70M | 2.20M | 18.60M | 21.40M |
| Net profit | 72.40M | 71.70M | 28.80M | 44.90M | -34.90M | -3.10M | 41.80M | 40.50M |
| Basic EPS | 1 | 1 | 0 | 1 | 0 | 0 | 1 | 1 |
| Diluted EPS | 1.04 | 1.03 | 0.45 | 0.63 | -0.49 | -0.04 | 0.52 | 0.53 |
| Line item | 2025-04 | 2025-07 | 2025-10 | 2026-01 | 2026-04 | 2026-07 |
|---|---|---|---|---|---|---|
| Revenue | 380.30M | 357.70M | 319.00M | 278.60M | 290.90M | 450.00M |
| Gross profit | 28.40M | 45.10M | 55.70M | 31.60M | 20.50M | 44.70M |
| Selling & admin expenses | 21.40M | 24.00M | 28.00M | 29.10M | 21.10M | 31.60M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 7.00M | 21.10M | 27.70M | 2.50M | -600.00K | 13.10M |
| Pretax profit | 4.70M | 19.80M | 28.00M | 1.00M | -8.70M | -5.20M |
| Tax | 1.70M | 5.30M | 11.20M | 1.10M | -1.30M | 600.00K |
| Net profit | 3.00M | 14.50M | 16.80M | -100.00K | -7.40M | -5.80M |
| Basic EPS | 0 | 0 | 0 | 0 | 0 | 0 |
| Diluted EPS | 0.04 | 0.21 | 0.22 | -0.01 | -0.10 | -0.08 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 156.90M | 206.00M | 248.10M | 247.10M | 228.10M | 220.10M | 279.00M | 262.20M |
| Cash & ST investments | 26.31M | 64.00M | 124.00M | 84.50M | 52.80M | 42.90M | 58.00M | 64.80M |
| Inventory | 32.32M | 44.90M | 38.60M | 48.20M | 73.10M | 70.80M | 91.20M | 80.60M |
| Total assets | 621.77M | 689.40M | 777.30M | 873.50M | 879.50M | 914.80M | 971.50M | 983.00M |
| Total current liabilities | 68.31M | 79.50M | 77.90M | 89.20M | 101.70M | 97.50M | 149.10M | 134.50M |
| Short-term debt | 8.45M | 7.30M | 8.60M | 13.50M | 11.90M | 15.90M | 15.90M | 17.70M |
| Long-term debt | 192.40M | 174.00M | 166.70M | 155.10M | 137.90M | 151.10M | 112.50M | 93.70M |
| Total liabilities | 308,322,000.00 | 310,400,000.00 | 303,800,000.00 | 339,300,000.00 | 356,600,000.00 | 386,500,000.00 | 394,400,000.00 | 363,100,000.00 |
| Total equity | 313.45M | 379.00M | 473.50M | 534.20M | 522.90M | 528.30M | 577.10M | 619.90M |
| Retained earnings | 174.08M | 239.30M | 251.20M | 309.00M | 274.40M | 271.00M | 307.70M | 339.30M |
| Line item | 2025-04 | 2025-07 | 2025-10 | 2026-01 | 2026-04 | 2026-07 |
|---|---|---|---|---|---|---|
| Total current assets | 297.10M | 284.70M | 262.20M | 273.60M | 283.60M | 401.90M |
| Cash & ST investments | 36.70M | 43.70M | 64.80M | 44.80M | 33.00M | 47.10M |
| Inventory | 112.80M | 103.40M | 80.60M | 99.30M | 116.60M | 141.30M |
| Total assets | 1.01B | 1.00B | 983.00M | 997.70M | 1.01B | 1.61B |
| Total current liabilities | 149.90M | 139.90M | 134.50M | 147.00M | 148.50M | 209.70M |
| Short-term debt | 11.70M | 15.30M | 17.70M | 14.00M | 14.80M | 29.20M |
| Long-term debt | 145.10M | 129.40M | 93.70M | 97.00M | 115.80M | 388.90M |
| Total liabilities | 426,200,000.00 | 401,900,000.00 | 363,100,000.00 | 377,600,000.00 | 396,600,000.00 | 807,000,000.00 |
| Total equity | 584.30M | 600.50M | 619.90M | 620.10M | 611.60M | 799.80M |
| Retained earnings | 309.20M | 323.90M | 339.30M | 338.60M | 329.20M | 315.50M |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 32.70M | 92.60M | 78.90M | 47.00M | 35.20M | 29.20M | 93.40M | 88.60M |
| Depreciation & amortization | 9.40M | 16.50M | 18.10M | 20.40M | 24.80M | 32.80M | 37.70M | 34.60M |
| Free cash flow | 5.50M | 62.90M | 11.60M | -26.40M | -26.00M | -20.60M | 61.20M | 37.20M |
| Dividends paid | -4.50M | -5.60M | -13.00M | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | 0 | -900.00K | 76.20M | 0 | 0 | -600.00K | 0 | -6.10M |
| Ending cash balance | 30.50M | 65.60M | 127.00M | 92.20M | 53.90M | 43.20M | 59.30M | 66.50M |
| Line item | 2025-04 | 2025-07 | 2025-10 | 2026-01 | 2026-04 | 2026-07 |
|---|---|---|---|---|---|---|
| Operating cash flow | -11.80M | 34.40M | 67.20M | -3.00M | -18.00M | -4.90M |
| Depreciation & amortization | 7.00M | 8.40M | 10.50M | 9.20M | 6.70M | 14.90M |
| Free cash flow | -25.00M | 22.60M | 55.60M | -14.90M | -29.00M | -14.00M |
| Dividends paid | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -5.20M | 0 | -600.00K | 0 | -2.20M | -7.20M |
| Ending cash balance | 39.00M | 46.60M | 66.50M | 47.40M | 35.10M | 48.30M |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 23.10 | 20.71 | 6.76 | 8.91 | -6.68 | -0.62 | 6.98 | 6.65 |
| ROA %i | 11.64 | 10.94 | 3.93 | 5.44 | -3.95 | -0.35 | 3.89 | 3.86 |
| ROIC %i | 14.74 | 14.44 | 5.20 | 6.61 | -4.34 | 0.60 | 5.78 | 5.50 |
| 5-year avg ROE %i | -- | -- | -- | -- | 10.56 | 5.83 | 3.08 | 3.06 |
| EBIT margin %i | 10.93 | 12.04 | 5.86 | 7.82 | -2.46 | 1.12 | 5.91 | 5.13 |
| FCF / sales %i | 0.64 | 7.12 | 1.35 | -- | -- | -- | 4.96 | 2.67 |
| Current ratioi | 2.30 | 2.59 | 3.18 | 2.77 | 2.24 | 2.26 | 1.87 | 1.95 |
| Quick ratioi | 1.66 | 1.90 | 2.54 | 2.02 | 1.39 | 1.43 | 1.18 | 1.25 |
| Debt / assetsi | 32.75 | 26.97 | 22.98 | 24.42 | 24.46 | 27.62 | 22.37 | 20.44 |
| LT debt / equityi | 62.28 | 47.12 | 35.90 | 37.40 | 40.47 | 47.02 | 36.80 | 31.19 |
| Interest coveragei | 17.41 | 10.30 | 7.54 | 18.84 | -4.67 | 0.92 | 5.79 | 7.59 |
| Revenue CAGR (3Y) %i | -- | -- | -- | 1.22 | 5.79 | 3.42 | 11.46 | 9.98 |
| Net income CAGR (3Y) %i | -- | -- | -- | -14.72 | -- | -- | -6.50 | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- | -- | -- |
| Line item | 2025-04 | 2025-07 | 2025-10 | 2026-01 | 2026-04 | 2026-07 |
|---|---|---|---|---|---|---|
| ROE %i | 6.89 | 7.12 | 6.65 | 5.82 | 4.03 | 0.24 |
| ROA %i | 3.71 | 3.97 | 3.86 | 3.32 | 2.26 | 0.12 |
| ROIC %i | 5.40 | 5.69 | 5.50 | 4.85 | 3.37 | 0.69 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 5.07 | 5.12 | 5.13 | 4.67 | 3.88 | 1.95 |
| FCF / sales %i | 1.79 | 0.89 | 2.67 | 2.87 | 2.75 | -- |
| Current ratioi | 1.98 | 2.04 | 1.95 | 1.86 | 1.91 | 1.92 |
| Quick ratioi | 1.13 | 1.18 | 1.25 | 1.09 | 1.03 | 1.13 |
| Debt / assetsi | 24.42 | 23.47 | 20.44 | 20.03 | 21.59 | 32.28 |
| LT debt / equityi | 42.57 | 38.68 | 31.19 | 31.66 | 35.07 | 64.06 |
| Interest coveragei | 6.66 | 7.45 | 7.59 | 7.01 | 5.83 | 2.37 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Single-engine
- Marketing & Distribution is the largest reported line at 92.07% of revenue, across 5 reported segments.
- The next-largest line, International Farming, is a distant second at 10.18% - a sharp slowdown here would have little to offset it.
Revenue breakdown most recent period
Business
Marketing & Distribution92.07%
International Farming10.18%
Prepared foods3.44%
Blueberries1.20%
Quote time 2026-10-08 08:35:05 · For reference only, not investment advice and not tailored to your situation.